« Back Urologic Oncology: Seminars and Original Investigations

Article in Press

Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis

  • Hung-Yu Lin, M.D., M.S.

      Affiliations

    • Department of Urology, E-DA Hospital/I-SHOU University, Kaohsiung, Taiwan
    • Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
  • ,
  • Ming-Chang Yang, M.S.

      Affiliations

    • Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan
    • Institute of Biological Science, National Sun Yat-sen University, Kaohsiung City, Taiwan
  • ,
  • Chun-Hsiung Huang, M.D.

      Affiliations

    • Department of Urology, Kaohsiung Medical University, Kaohsiung, Taiwan
  • ,
  • Wen-Jen Wu, M.D.

      Affiliations

    • Department of Urology, Kaohsiung Medical University, Kaohsiung, Taiwan
  • ,
  • Tsan-Jung Yu, M.D.

      Affiliations

    • Department of Urology, E-DA Hospital/I-SHOU University, Kaohsiung, Taiwan
  • ,
  • For-Wey Lung, M.D., Sc.D.

      Affiliations

    • Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan
    • Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan
    • National Defense Medical Center, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. Tel.: +886-2-2726-3141; fax: +886-2-2728-5059.

Received 21 September 2011 ,Revised 9 November 2011 ,Accepted 15 November 2011. Published online 19 December 2011 Corrected Proof

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 ☆This study was supported by grants (numbers T3-03 and T3-04) from the , Ministry of National Defense, Taiwan.

PII: S1078-1439(11)00435-2

doi: 10.1016/j.urolonc.2011.11.031

« Back Urologic Oncology: Seminars and Original Investigations

Article in Press